Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre- and post-COVID-19 pandemic
Hospital RSV burden in children is significant but currently not fully monitorable. Further efforts to harmonise coding practices both within and across countries would improve the quality of future analyses. Additional data in future seasons should complement current outcomes to inform decisions regarding RSV prevention.
Authors
- David Gideonse
- Caroline Klint Johannesen (ORCID: https://orcid.org/0000-0001-6503-5632)
- Rolf Kramer (ORCID: https://orcid.org/0000-0002-6095-4338)
- Arantxa Urchueguía-Fornes (ORCID: https://orcid.org/0000-0003-4689-9077)
- Kocfa Chung-Delgado (ORCID: https://orcid.org/0000-0003-1962-9434)
- Alejandro Orrico‐Sánchez (ORCID: https://orcid.org/0000-0002-3780-3187)
- Terho Heikkinen (ORCID: https://orcid.org/0000-0001-6504-0116)
- Toni Lehtonen (ORCID: https://orcid.org/0000-0003-2089-2299)
- Ombeline Jollivet
- Richard Osei‐Yeboah (ORCID: https://orcid.org/0000-0003-4622-3691)
- Thea Kølsen Fischer (ORCID: https://orcid.org/0000-0003-4812-980X)
- Michiel van Boven (ORCID: https://orcid.org/0000-0002-0841-2400)
- Harry J. Campbell (ORCID: https://orcid.org/0000-0002-6169-6262)
- Harish Nair (ORCID: https://orcid.org/0000-0002-9432-9100)
- Rachel Cohen (ORCID: https://orcid.org/0000-0002-5277-1822)
Institutions
- Statens Serum Institut (DK)
- University of Turku (FI)
- Turku University Hospital (FI)
- Sanofi (France) (FR)
- Finnish Institute for Health and Welfare (FI)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Universities at Shady Grove (US)
- National Institute for Public Health and the Environment (NL)
- GlaxoSmithKline (United States) (US)
- Centre for Global Health Research (CA)
- University of Edinburgh (GB)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1016/j.ijid.2025.107903
- Citations
- 5
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- European Federation of Pharmaceutical Industries and Associations
- European Commission
- Innovative Medicines Initiative